男子不妊症に対するMethylcobalamin(CH3-Bl2)とClomiphene citrateの併用療法の経験
スポンサーリンク
概要
- 論文の詳細を見る
Infertile men (excluding azoospermia) were divided into three groups to test methylcobalamin (CH3-B12) + clomiphene citrate (Clomid) treatment. Group M: CH3-B12 (1,500 micrograms/day, daily for 8 to 60 weeks), Group C: Clomid (25 mg/day for 25 days followed by a 5-day rest period, for 8 to 48 weeks), and Group MC: CH3-B12 + Clomid (CH3-B12: 1,500 micrograms/day, daily and Clomid: 25 mg/day for 25 days followed by a 5-day rest period, for 12 to 24 weeks semen analysis was conducted before and after these administrations. Judging by our criteria, 60.0% (24/40) of the cases in Group M, 71.4%(25/35) in Group C, and 66.7% (8/12) in Group MC were improved. However, in patients whose sperm concentrations were over 10 X 10(6)/ml, 61.9% (13/21) of the cases in Group M, 69.2% (9/13) in Group C, and 80.0% (4/5) in Group MC were improved. Therefore, CH3-B12 + Clomid treatment was successful for patients whose sperm concentrations was over 10 X 10(6)/ml.
論文 | ランダム
- 職業安定行政における臨時工
- Immunodeficiency-Malignancy Association at Autopsy in Japan
- Thromboplastic and Fibrinolytic Activities of V2 and V7 Carcinomas of Rabbit,with Special Reference to Fibrin Deposition and Thrombus Formation in the Tumors
- 高速液体ジェット加工法の進歩とその可能性 (最近の特殊加工(特集))
- 高速液体ジェット加工法 その現状と展望